about
The expanding regulatory universe of p53 in gastrointestinal cancerMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaCluster microRNAs miR-194 and miR-215 suppress the tumorigenicity of intestinal tumor organoidsMiRNA profiling of gastrointestinal stromal tumors by next-generation sequencingIdentification and functional screening of microRNAs highly deregulated in colorectal cancerIdentification and pathway analysis of microRNAs with no previous involvement in breast cancer.Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis.MicroRNAs as promising biomarkers in cancer diagnostics.MicroRNA transcriptome in swine small intestine during weaning stress.Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.Deep sequencing, profiling and detailed annotation of microRNAs in Takifugu rubripes.Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim.miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer.The role of microRNAs in colorectal cancer.CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.Inhibition of autophagy and tumor growth in colon cancer by miR-502.A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive reviewEpigenetic analysis of the Notch superfamily in high-grade serous ovarian cancerReduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemiaUrine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.MicroRNA profiling of carcinogen-induced rat colon tumors and the influence of dietary spinach.Prognostic significance of miR-194 in endometrial cancer.microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer.MicroRNAs in colorectal cancer as markers and targets: Recent advances.MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.MicroRNAs in the p53 network: micromanagement of tumour suppression.MicroRNAs and inflammation in the pathogenesis and progression of colon cancer.MicroRNAs and anticancer drugs.MicroRNA dysregulation as a prognostic biomarker in colorectal cancerMicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.miR-215 suppresses proliferation and migration of non-small cell lung cancer cellsMicroRNA-215 enhances invasion and migration by targeting retinoblastoma tumor suppressor gene 1 in high-grade glioma.A miRNA signature for an environmental heterocyclic amine defined by a multi-organ carcinogenicity bioassay in the rat.
P2860
Q26742058-127AC00B-DEC6-4DF4-9907-61BB9EE2A9BBQ26775610-CA63555E-F786-48A3-86B6-EF398406A7BAQ27024427-FC41BDA8-741D-4517-AA24-FA72BE8B358DQ28397829-C5ABE69F-6B5C-48C5-9A03-C26CFD3C4988Q33607429-1CFC4A1D-0DD1-48A2-8F50-235B0300E5DEQ33913895-88F9A6A5-D797-4FB6-909B-9C66ADBFC871Q33985952-39234139-C471-4396-B216-E0C9143184DFQ34206037-57E5DF50-9E95-4867-94B8-BED74FCA82D6Q34404162-0E9FC2B2-CE58-42A9-8CD3-38FC37E23CD1Q34417467-E15AD8B9-F576-488B-9525-43D81F18F7DCQ35048355-196753B5-BD0E-4653-8A00-8094455710E7Q35565247-C36C654B-AC03-4F12-A260-1ABAB2310ADCQ35580945-62997B87-511E-41B6-A5AB-806757C53371Q35664681-5F78F192-73C1-4F95-A3D0-091A50BECBB3Q36014262-26BA4FC7-A96C-4516-8127-B53D70638D33Q36085367-6F78EFD4-35D3-4F94-8F3B-8F1B6D78AA94Q36096641-9C325D0F-7E29-4A86-A35F-0C79AD5CE600Q36103111-8E675C1F-C111-4B9C-A730-0CB76CC81E8DQ36173829-340253F1-646A-4C6F-A55B-5F2423A344D5Q36318344-48D66D25-AA9A-4F1E-9706-25B4E5551CFCQ36480448-B4302934-F19F-44F5-A65D-7556C88FAD92Q36646576-6D1E661A-A32E-4ED9-91A8-C680CF7C38A0Q36819232-E7402A54-62FF-4998-BFB1-16848C3D4461Q36949308-95FD6254-5F03-4E4E-A440-0B9A0806E5EBQ36997188-FB71B116-5FFA-4696-9CFB-7320BD8E5C78Q37146244-993CA6CC-1DD8-4F64-AACB-4379323F700AQ37169644-D105EB94-5267-40D9-8738-00F097F77C64Q37466124-972E5721-4E9D-46E5-9B03-170B10A20695Q37685240-1FF95064-9E68-4EF2-BE3F-512652600D51Q37708024-2FE921BD-5645-4F61-AF53-6F8CF313F050Q37731180-7ACD3507-478E-4AAD-949A-25BDA131E037Q38035144-CD19C186-D482-400E-B595-7B9684CF540CQ38064738-AD5DFC78-DCAD-4EAC-AD60-01280425E4AAQ38184857-C510584D-A147-4884-8C94-C37B1BF4BBE2Q38262497-9F83ABF2-500B-482B-B133-1CEC5AA9089CQ38550157-AFB50427-056F-459B-8CF6-F8B8AFC1B599Q38555225-BED116E1-6735-45DD-88DC-D263ABBDB48CQ38705622-12CA72D9-4BB3-46A4-B8FA-F81C742D9594Q38731609-C1FD1B88-5FD8-424A-A8CC-9BD1F1A64AFDQ38746340-8F3D23B6-717F-4594-A97C-3179722A16F9
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prognostic significance of miR-215 in colon cancer.
@ast
Prognostic significance of miR-215 in colon cancer.
@en
type
label
Prognostic significance of miR-215 in colon cancer.
@ast
Prognostic significance of miR-215 in colon cancer.
@en
prefLabel
Prognostic significance of miR-215 in colon cancer.
@ast
Prognostic significance of miR-215 in colon cancer.
@en
P2093
P2860
P1476
Prognostic significance of miR-215 in colon cancer.
@en
P2093
Cecilia Zhang
Kenneth Shroyer
Mihriban Karaayvaz
Penelope Georgakopoulos
Saira Mehmood
Stephanie Burke
Timothy Pal
P2860
P304
P356
10.1016/J.CLCC.2011.06.002
P407
P50
P577
2011-07-12T00:00:00Z